Food and Drug Administration (FDA) commissioner Marty Makary on Friday said the agency has not finalized a forthcoming report about autism after the Wall Street Journal reported Health Secretary Robert F. Kennedy Jr. is expected to make an announcement linking Tylenol to the condition in children, urging mothers carrying children to forego the pain medication.

“The report is not written, so there's nothing really to report, because we're still in our discussions. I think the interest in Tylenol by The Wall Street Journal probably stems from the Harvard study on Tylenol and autism that came out recently,” Makary said during a Friday appearance on NewsNation’s “The Hill.”

“But our report is not yet written,” he added.

Makary said the president and Kennedy have made research about autism c

See Full Page